RIL
AKTS

Rothschild Investment LLC’s Aktis Oncology AKTS Stock Holding History

Rothschild Investment LLC’s Portfolio AKTS Stock Details AKTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.26K Buy
+39
New +$801 ﹤0.01% 2969

Other funds holding AKTS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MC
Merck & Co Kenilworth, New Jersey $526M AUM 175.27% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
MCP
Mirador Capital Partners Pleasanton, California $817M AUM 42.46% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
CG
Caprock Group Boise, Idaho $5.22B AUM 42.47% 1-Year Est. Return

Rothschild Investment LLC's AKTS Position: Q2 2026 in Review

Rothschild Investment LLC opened a new position in Aktis Oncology (AKTS) in Q2 2026: 39 shares worth $1.26K. The stake represents ﹤0.01% of the portfolio and ranks #2969 among its holdings.

37 funds tracked by Wall St. Rank hold AKTS as of Q2 2026.

  • Rothschild Investment LLC held 39 shares of Aktis Oncology worth $1.26K as of Q2 2026.
  • Aktis Oncology was a new Rothschild Investment LLC position in Q2 2026.
  • Aktis Oncology made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #2969 holding.
  • 37 funds tracked by Wall St. Rank held Aktis Oncology as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.